Navigation Links
R-CALF United Stockgrowers of America: 'Fighting for the U.S. Cattle Producer'
Date:10/31/2007

WASHINGTON, Oct. 31 /PRNewswire-USNewswire/ -- The following is being issued by R-CALF United Stockgrowers of America:

WHAT: R-CALF USA will hold a news conference about the lawsuit it and 10 other plaintiffs filed against the U.S. Department of Agriculture (USDA) to prevent the agency from allowing into the United States older Canadian cattle and beef products from Canadian cattle over 30 months (OTM) of age, scheduled to begin Nov. 19. The plaintiffs maintain that Canada's problems with bovine spongiform encephalopathy (BSE), or mad cow disease, pose a threat both to the health of the U.S. cattle herd and to U.S. beef consumers.

WHEN: 9 a.m. EDT, West Room, National Press Club, Washington, D.C.

HOW: To participate, reporters can call 1-800-926-6734.

PLAINTIFFS who will be present:

R-CALF USA CEO Bill Bullard

Consumer Federation of America's Food Policy Institute Director Chris Waldrop

Creutzfeldt-Jakob Disease Foundation President Florence Kranitz

South Dakota Stockgrowers Association President Larry Nelson

R-CALF USA Counsel Russ Frye

R-CALF USA Counsel Will Miller

BACKGROUND NEWS RELEASE available under the "News Releases" link at

http://www.r-calfusa.com, or by contacting R-CALF USA Communications Coordinator Shae Dodson.

PLAINTIFFS unable to attend:

Food & Water Watch

Center for Food Safety

Public Citizen

South Dakota cattle producers Herman Schumacher, Bob Mack, Ernie Mertz and Wayne Nelson

To arrange interviews with plaintiffs not in attendance, contact Dodson at the e-mail address or phone number above.

R-CALF USA (Ranchers-Cattlemen Action Legal Fund, United Stockgrowers of America) is a national, non-profit organization dedicated to ensuring the continued profitability and viability of the U.S. cattle industry. R-CALF USA represents thousands of U.S. cattle producers on trade
'/>"/>

SOURCE R-CALF United Stockgrowers of America
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
2. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
3. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
4. Alzheimers Drug Shows Promise in Fighting Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, ... President and Chief Financial Officer. In this role, ... administrative functions including finance, accounting, IT, IR, administration and ... Company,s senior management team. ,, "One of my ...
(Date:12/4/2009)... Shore and E. David Crawford presented results for prostate-specific ... end points of biochemical recurrence rate in a Phase ... or monthly leuprolide in prostate cancer patients during the ... received FIRMAGON 240/80 mg/month had a recurrence rate of ...
(Date:12/3/2009)... a subsidiary of Hill-Rom Holdings, Inc. (NYSE: ... Allen Amatech(TM) OEM (Original Equipment Manufacturer) business website ... the Allen Amatech(TM) brand identity and includes an online ... and design specifications for the products. "We hope to ...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 1Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 2Univisions Doctora Aliza Launches VidaySalud com 28TM 29 48017 1Univisions Doctora Aliza Launches VidaySalud com 28TM 29 48017 2Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 1Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 2Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 3Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 4
... ALISO VIEJO, Calif.--(BUSINESS WIRE)--Jun 8, 2007 ... presentation of,Phase III data, including efficacy, ... patients with diabetic peripheral,neuropathic (DPN) pain ... (DM/Q)), an NMDA receptor,antagonist and sigma-1 ...
... Data presented at Movement Disorder Society’s 11th,International ... early,Parkinson’s disease patients is a critical unmet ... – Merck Serono S.A.,(virt-x: SEO) and its ... data, which suggest that safinamide, a new,agent ...
Other Medicine Technology:AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 2AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 3AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 4AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 5AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 6AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 7Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 2Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 3Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 4Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 5Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 6Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 7
(Date:12/7/2009)... Researchers at the University of Chicago have discovered a ... has obstructive sleep apnea (OSA) or habitual snoring by ... the possibility of developing a relatively simple urine test ... alleviate the need for costly and inconvenient sleep studies ... percent of whom actually have OSA," said lead author ...
(Date:12/6/2009)... become a mainstay of multiple myeloma treatment may ... of patients who have received stem cell transplants ... clinical trial results to be presented by ... Society of Hematology,s (ASH) annual meeting on Sunday, ... Center, Room 243-245, 5:45 pm CT). , ...
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... 2b 003-A1 study, known as the 003 trial, ... relapsed and refractory multiple myeloma patients. These data ... at the 51st annual meeting of the American ... in this trial is complete (n=269), and full ...
(Date:12/6/2009)... of the community, in cooperation with the Greater VA Healthcare System ... This year,s attendance is expected to soar to more than 5,000 ... ... (PRWEB) December 6, 2009 -- Volunteer organizations and members ... in West Los Angeles, will once again create a holiday party. ...
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
Breaking Medicine News(10 mins):Health News:Urine test for pediatric obstructive sleep apnea possible 2Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3
... most common reason for hospitalizations, analysis finds , , WEDNESDAY, ... 1.2 million Americans -- roughly equivalent to the population ... government analysis of hospital admissions and costs found. , ... common reason for admission to hospital, and treating these ...
... Pa., July 2 David Belkin died,last February during a ... he is alive to tell about it., On Sunday, ... his hero.,He,ll present Matlaga with the Sudden Cardiac Arrest (SCA) ... Henry Skier, at,13 Hillcrest Rd. (behind Wayne Memorial Hospital) in ...
... and Georgia Reach Statewide Olmstead,Settlement Agreement, WASHINGTON, ... currently institutionalized in Georgia,s,eight public psychiatric hospitals and ... in their communities with appropriate supports,tailored to meet ... settlement,agreement between the state of Georgia and the ...
... to the gym, take simple steps to avoid the ... -- Before heading to the gym, you should brush ... deadly superbug, say doctors from Loyola University. , While ... hospitals and health-care settings, they are on the rise ...
... Medicare Advantage face significant funding cuts under legislation ... by America,s Health,Insurance Plans., As Congress considers ... in Medicare, many are looking at the Medicare ... being considered (H.R. 6331) would,cut $143 million from ...
... 2 New Hampshire seniors,enrolled in Medicare Advantage ... Congress, according to new data released by,America,s Health ... halt the impending cut to physician,payments in Medicare, ... to,pay for the fix. Legislation currently being considered ...
Other Medicine News:Health News:Back From the Dead: Cardiac Arrest Victim Salutes His Rescuer 2Health News:Georgia to Offer More Community Living Alternatives for Individuals With Disabilities 2Health News:Georgia to Offer More Community Living Alternatives for Individuals With Disabilities 3Health News:MRSA Infections Can Bug Fitness Buffs 2Health News:Proposed Congressional Legislation Would Cut $143 Million from the Medicare Advantage Program in Georgia 2Health News:Proposed Congressional Legislation Would Cut $6.6 Million from the Medicare Advantage Program in New Hampshire 2
... EpochXP Workstations provide comprehensive neurological monitoring ... care unit to accurately access your ... over 15 years experience, and a ... EpochXP neurological monitoring systems have a ...
... powerful, multi-modality system capable of performing EP (including ... and train of four testing tests simultaneously. The ... The base weighs only 4.25 lbs. A complete ... desktop PC-based system with a custom cart can ...
... neuromonitoring system especially designed for surgical monitoring ... 16 channels and is equipped with two ... channel can be independently configured as either ... channel. Endeavor amplifiers are based on the ...
... Katena Products, Inc. is the ... dedicated exclusively to ophthalmic surgical ... to over 7,000 customers in ... a global network of distributors, ...
Medicine Products: